KEMIRA Kemira Oyj

Kemira provides an outlook for H2 2020: Operative EBITDA in H2 2020 expected to be lower than in H1 2020

Kemira provides an outlook for H2 2020: Operative EBITDA in H2 2020 expected to be lower than in H1 2020

Kemira Oyj

Inside information

July 17, 2020 at 8.30 am (CET+1)

Kemira provides an outlook for H2 2020: Operative EBITDA in H2 2020 expected to be lower than in H1 2020





In conjunction with its Half-Year Financial Report for 2020 published today July 17, 2020, Kemira provided an outlook for the second half of 2020.

OUTLOOK FOR JULY-DECEMBER 2020

Operative EBITDA in H2 2020 is expected to be lower than in H1 2020 (H1 2020: EUR 214 million).

Assumptions behind Kemira's outlook for July-December 2020:

Overall demand in Kemira's end markets in H2 2020 is expected to be approximately at the same level as in Q2 2020. Demand in Pulp & Paper is expected to remain approximately at the Q2 2020 level, with printing and writing demand to remain weak. Also in Industry & Water, demand is expected to remain approximately at the Q2 2020 level. The shale market is not anticipated to recover in 2020.

Kemira's outlook for H2 2020 assumes no significant disruptions to Kemira's manufacturing operations or supply chain.

Previous outlook (published April 27, 2020):

On April 27, 2020, Kemira withdrew its outlook for 2020 due to the uncertainty following the COVID-19 pandemic and the oil price drop.

For more information, please contact:



Kemira Oyj

Mikko Pohjala, Vice President, Investor Relations

Tel. +358 40 838 0709

Kemira is a global chemicals company serving customers in water intensive industries. We provide best suited products and expertise to improve our customers’ product quality, process and resource efficiency. Our focus is on pulp & paper, oil & gas and water treatment. In 2019, Kemira had annual revenue of around EUR 2.7 billion and over 5,000 employees. Kemira shares are listed on the Nasdaq Helsinki Ltd.

 

EN
17/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kemira Oyj

Kemira Oyj: 1 director

A director at Kemira Oyj bought 4,000 shares at 18.380EUR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Tomi Railo
  • Tomi Railo

Kemira (Buy, TP: EUR23.00) - Softening in packaging

We have cut our 2025–2027e clean EPS by an average of c4% on a weaker than expected Q1 and our lowered estimates, mainly for Packaging & Hygiene and Fiber. The share price suggests an attractive 2025e EV/EBITDA of c5.5x and c25% upside potential to our lowered target price of EUR23 (25). We reiterate our BUY.

Tomi Railo
  • Tomi Railo

Kemira (Buy, TP: EUR25.00) - Focus on demand comments

Our focus in the Q1 results (due on 25 April, no details yet) will be clean EBITDA and demand comments, which may reflect increased uncertainty. We have cut our 2025–2027e clean EPS by c4% and our target price to EUR25 (27), but reiterate our BUY.

Mattias Holmberg
  • Mattias Holmberg

Who stands to benefit?

A potential peace deal between Russia and Ukraine could unlock one of the largest reconstruction efforts in modern history. The World Bank estimates Ukraine will need USD486bn in rebuilding efforts over the next decade, but we estimate this would add only c2% to annual European construction spending. While the direct earnings effect may be modest, we expect the “rebuild Ukraine theme” to drive investor sentiment. We see Volvo, Epiroc, Hexagon, Metso, Hiab and ABB as some of the primary beneficia...

Tomi Railo
  • Tomi Railo

Kemira (Buy, TP: EUR27.00) - Attractive quality and stability

After tweaking our 2025–2026e clean EPS following the Q4 results, we reiterate our BUY and EUR27 target price. In our view, earnings quality and stability are attractively valued at a 2025e EV/EBITDA of c6x versus the wider chemicals peer group on c7.5x.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch